Use of cannabinoids in the treatment of epilepsy
US-2025177321-A1 · Jun 5, 2025 · US
This page is not indexed by search engines while we improve data quality.
Guy Geoffrey patents
Guy Geoffrey is listed as an inventor on 152 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Guy Geoffrey |
| Total patents | 152 |
| First publication | Mar 26, 2015 |
| Latest publication | Jun 5, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders
US-12150927-B2 · Nov 26, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-12064399-B2 · Aug 20, 2024 · US
Use of cannabidiol in the treatment of nocturnal snoring
US-2024261234-A1 · Aug 8, 2024 · US
Cannabidiol preparations and its uses
US-2024207220-A1 · Jun 27, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2024165048-A1 · May 23, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-11963937-B2 · Apr 23, 2024 · US
Use of cannabidiol preparations in the treatment of temporal lobe epilepsy
US-2024091241-A1 · Mar 21, 2024 · US
Use of cannabinoids in the treatment of epilepsy
US-2024033229-A1 · Feb 1, 2024 · US
Cannabidiol preparations and its uses
US-11865102-B2 · Jan 9, 2024 · US
Recent patents
Latest publications not already listed above.
Use of cannabinoids in the treatment of epilepsy
US-2023301936-A1 · Sep 28, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11766411-B2 · Sep 26, 2023 · US
Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia
US-11752111-B2 · Sep 12, 2023 · US
Use of cannabinoids in the treatment of angelman syndrome
US-2023263744-A1 · Aug 24, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2023248664-A1 · Aug 10, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11701330-B2 · Jul 18, 2023 · US
Use of cannabinoids in the treatment of Angelman syndrome
US-11679087-B2 · Jun 20, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-11633369-B2 · Apr 25, 2023 · US
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US-2023068885-A1 · Mar 2, 2023 · US
Cannabidiol-type cannabinoid compound
US-11590087-B2 · Feb 28, 2023 · US
Use of cannabidiol in the treatment of nocturnal snoring
US-2023032502-A1 · Feb 2, 2023 · US
Cannabidiol-type cannabinoid compound
US-2023026079-A1 · Jan 26, 2023 · US
Cannabidiol-type cannabinoid compound
US-2023022487-A1 · Jan 26, 2023 · US
Cannabidiol-type cannabinoid compound
US-2023000789-A1 · Jan 5, 2023 · US
Use of cannabinoids in the treatment of epilepsy
US-2022395471-A1 · Dec 15, 2022 · US
(+)-cis tetrahydrocannabinol ((+)-cis-thc) for use as a medicament
US-2022387377-A1 · Dec 8, 2022 · US
Use of cannabinoids in the treatment of epilepsy
US-2022387348-A1 · Dec 8, 2022 · US
Cannabidivarin preparations for use as a medicament
US-2022387350-A1 · Dec 8, 2022 · US
(+)-trans tetrahydrocannabinol ((+)-trans-thc) for use as a medicament
US-2022378738-A1 · Dec 1, 2022 · US
Use of cannabidiol preparations in the treatment of fragile x syndrome
US-2022378714-A1 · Dec 1, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Gw Res Ltd | 95 |
| Gw Pharma Ltd | 57 |
| Otsuka Pharma Co Ltd | 8 |
| Guy Geoffrey | 7 |
| Stott Colin | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/658 | 151 |
| A61K31/05 | 143 |
| A61K36/185 | 130 |
| A61P25/08 | 121 |
| A61K45/06 | 112 |